Chemistry engineering specialists Vapourtec of Bury St Edmunds saw its turnover soar last year by 15 per cent.
The company, based in Park Farm Business Centre, Fornham St Genevieve, has lead breakthroughs in the more efficient production of the breast cancer drug Tamoxifen and the malaria drug Artemisinin.
We’ve experienced another year of rapid growth.Duncan Guthrie, managing director
It says the growth in turnover is due to a heightened awareness of the benefits of its flow chemistry systems.
Duncan Guthrie, founder and managing director of Vapourtec, which employs about 14 staff, said; “We’ve experienced another year of rapid growth and this reflects growing awareness of the benefits and the impressive economies of scale that can be delivered by flow chemistry.
“Flow chemistry systems, including those manufactured by ourselves, are playing a big role in bringing down the cost of producing pharmaceutical drugs and industrial chemicals as well as contributing to many major published research breakthroughs.
“Our own systems have been cited in over 180 published, peer-review papers and the pace of those breakthroughs is increasing year on year.”
The firm says interest in its work has doubled over five years during which turnover has risen by 100 per cent.
Vapourtec designs and manufactures flow chemistry systems for a variety of sectors including education, pharmaceutical and industry with their technologies used by all of the major pharmaceutical brands.
The company was created 13 years ago and has developed a flourishing international market for its technology with sales across much of the world including USA, China, Japan, Singapore and India.